Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 625.00 | 241.23 | 1313.00 | 1107.50 | 1.1856 | 1.1610 |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1128.00 | 1107.50 | 1.0185 | 1.0168 | |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 625.00 | 241.23 | 1028.00 | 1107.50 | 0.9282 | 0.9334 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 625.00 | 241.23 | 1396.00 | 1107.50 | 1.2605 | 1.2221 |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1500.00 | 1107.50 | 1.3544 | 1.2959 | |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 625.00 | 241.23 | 850.00 | 1107.50 | 0.7675 | 0.7732 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 625.00 | 241.23 | 1078.00 | 1107.50 | 0.9734 | 0.9756 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 625.00 | 241.23 | 655.00 | 1107.50 | 0.5914 | 0.5750 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 625.00 | 241.23 | 361.00 | 1107.50 | 0.3260 | 0.2012 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 625.00 | 241.23 | 861.00 | 1107.50 | 0.7774 | 0.7836 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 625.00 | 241.23 | 1076.00 | 1107.50 | 0.9716 | 0.9739 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 625.00 | 241.23 | 1051.00 | 1107.50 | 0.9490 | 0.9529 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 625.00 | 241.23 | 1154.00 | 1107.50 | 1.0420 | 1.0378 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 625.00 | 241.23 | 1065.00 | 1107.50 | 0.9616 | 0.9647 |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1047.00 | 1107.50 | 0.9454 | 0.9496 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2430.00 | 2597.00 | 0.9357 | 0.9435 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2541.00 | 2597.00 | 0.9784 | 0.9813 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 1250.00 | 520.59 | 844.00 | 2597.00 | 0.3250 | 0.2317 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2692.00 | 2597.00 | 1.0366 | 1.0312 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2648.00 | 2597.00 | 1.0196 | 1.0168 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2851.00 | 2597.00 | 1.0978 | 1.0821 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 1250.00 | 520.59 | 3060.00 | 2597.00 | 1.1783 | 1.1466 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 3099.00 | 2597.00 | 1.1933 | 1.1584 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 3154.00 | 2597.00 | 1.2145 | 1.1748 | |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 3077.00 | 2597.00 | 1.1848 | 1.1518 |